Browsing by Subject "HCC, targeted therapy, VEGF, Ras/Raf/MEK/ERK, PI3K/Akt/PTEN/mTOR, signal transduction inhibitors, cancer"
Now showing items 1-1 of 1
-
Targeted therapy for hepatocellular carcinoma: Novel agents on the horizon
(2012-03-31)Hepatocellular carcinoma (HCC) is the most common liver cancer, accounting for 90% of primary liver cancers. In the last decade it has become one of the most frequently occurring tumors worldwide and is also considered to ...